MLTX FY 2023 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$54M

Net Income

-$36M

EPS (Diluted)

$-0.73

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$527M

Total Liabilities

$13M

Stockholders' Equity

$496M

Cash & Equivalents

$451M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$54M	-$65M	+16.8%
Net Income	-$36M	-$50M	+27.9%